Business TechBaxter International Spends Close To $1B On Cancer Drugmaker American health care company Baxter International has purchased two cancer drugs from Sigma-Tau Finanziaria SpA valued at $900 million. Both drugs are designed to treat patients with a rare form of blood cancer called acute lymphoblastic leukemia.by Ted Ranosa
Business TechWill The Huffington Post And Other Publishers Be Spun Off As Part Of Verizon’s $4.4B Acquisition Of AOL?by Fergal Gallagher
Business TechNintendo, Universal Partner To Set Up Theme Park Attractions: Nintendo Land, Here We Come!by Christian de Looper
Business TechTencent Will Invest $126 Million In Kim Kardashian Game Developer Glu Mobileby Menchie Mendoza
Business TechGoldman Sachs Backs Bitcoin With $50M Investment In Wallet Startup Circleby Fergal Gallagher